Exousia Bio (LMMY) Payables (2025 - 2026)

Exousia Bio (LMMY) has 5 years of Payables data on file, last reported at $212302.0 in Q1 2026.

• Quarterly Payables changed N/A year-over-year to $212302.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $212302.0 (changed N/A YoY) and the FY2024 annual result came in at $29000.0, changed 0.0% from the prior year.
• Payables was little changed at $212302.0 in Q1 2026 per LMMY's latest filing, from $212302.0 in the prior quarter.
• The five-year high for Payables was $212302.0 in Q4 2025, with the low at $29000.0 in Q2 2022.
• Average Payables over 5 years is $65660.4, with a median of $29000.0 recorded in 2022.
• The widest YoY moves for Payables: up 0.0% in 2023, down 0.0% in 2023.
• Exousia Bio's Payables stood at $29000.0 in 2022, then changed by 0.0% to $29000.0 in 2023, then changed by 0.0% to $29000.0 in 2024, then soared by 632.08% to $212302.0 in 2025, then changed by 0.0% to $212302.0 in 2026.
• Business Quant data shows LMMY's Payables at $212302.0 in Q1 2026, $212302.0 in Q4 2025, and $29000.0 in Q3 2024.